These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 2405863)
1. Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials. Felson DT; Anderson JJ; Meenan RF Arthritis Rheum; 1990 Jan; 33(1):140-9. PubMed ID: 2405863 [TBL] [Abstract][Full Text] [Related]
2. What treatments for rheumatoid arthritis can best be assessed by large, simple, long-term trials? Peto R Br J Rheumatol; 1983 Aug; 22(3 Suppl):3-8. PubMed ID: 6871592 [TBL] [Abstract][Full Text] [Related]
3. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response. American College of Rheumatology Committee to Reevaluate Improvement Criteria Arthritis Rheum; 2007 Mar; 57(2):193-202. PubMed ID: 17330293 [TBL] [Abstract][Full Text] [Related]
4. Issues in the design of new clinical trials for rheumatoid arthritis therapeutics. Schwieterman WD Nat Clin Pract Rheumatol; 2008 Dec; 4(12):641-8. PubMed ID: 19037225 [TBL] [Abstract][Full Text] [Related]
5. Secular changes in published clinical trials of second-line agents in rheumatoid arthritis. Anderson JJ; Felson DT; Meenan RF Arthritis Rheum; 1991 Oct; 34(10):1304-9. PubMed ID: 1930319 [TBL] [Abstract][Full Text] [Related]
6. The design of clinical trials aimed at assessing the DC-ART properties of new molecules in rheumatoid arthritis. Ortiz Z; Tugwell P; Yocum D Clin Exp Rheumatol; 1997; 15 Suppl 17():S39-44. PubMed ID: 9266131 [TBL] [Abstract][Full Text] [Related]
7. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D Ann Rheum Dis; 2008 Oct; 67(10):1360-4. PubMed ID: 18791055 [TBL] [Abstract][Full Text] [Related]
9. On the design of the Phase III drug trial. The example of rheumatoid arthritis. Hadler NM; Gillings DB Arthritis Rheum; 1983 Nov; 26(11):1354-61. PubMed ID: 6639694 [TBL] [Abstract][Full Text] [Related]
10. A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis. Kirkham JJ; Clarke M; Williamson PR BMJ; 2017 May; 357():j2262. PubMed ID: 28515234 [No Abstract] [Full Text] [Related]
11. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Felson DT; Anderson JJ; Boers M; Bombardier C; Chernoff M; Fried B; Furst D; Goldsmith C; Kieszak S; Lightfoot R Arthritis Rheum; 1993 Jun; 36(6):729-40. PubMed ID: 8507213 [TBL] [Abstract][Full Text] [Related]
12. Where are we now with radiographic assessment of rheumatoid arthritis? Wood PH Br J Rheumatol; 1983 Aug; 22(3 Suppl):24-33. PubMed ID: 6347308 [TBL] [Abstract][Full Text] [Related]
17. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Felson DT; Smolen JS; Wells G; Zhang B; van Tuyl LH; Funovits J; Aletaha D; Allaart CF; Bathon J; Bombardieri S; Brooks P; Brown A; Matucci-Cerinic M; Choi H; Combe B; de Wit M; Dougados M; Emery P; Furst D; Gomez-Reino J; Hawker G; Keystone E; Khanna D; Kirwan J; Kvien TK; Landewé R; Listing J; Michaud K; Martin-Mola E; Montie P; Pincus T; Richards P; Siegel JN; Simon LS; Sokka T; Strand V; Tugwell P; Tyndall A; van der Heijde D; Verstappen S; White B; Wolfe F; Zink A; Boers M Ann Rheum Dis; 2011 Mar; 70(3):404-13. PubMed ID: 21292833 [TBL] [Abstract][Full Text] [Related]
18. Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard? Boers M Arthritis Rheum; 2003 Jun; 48(6):1481-3. PubMed ID: 12794813 [No Abstract] [Full Text] [Related]
19. Comparison of rheumatoid arthritis clinical trial outcome measures: a simulation study. Anderson JJ; Bolognese JA; Felson DT Arthritis Rheum; 2003 Nov; 48(11):3031-8. PubMed ID: 14613263 [TBL] [Abstract][Full Text] [Related]
20. Mean changes versus dichotomous definitions of improvement. Anderson JJ Stat Methods Med Res; 2007 Feb; 16(1):7-12. PubMed ID: 17338291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]